1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Veterinary Vaccines Market Size Growth Rate by Type: 2018 VS 2022 VS 2030
1.2.2 Inactivated Vaccines
1.2.3 Live Attenuated Vaccines
1.2.4 Conjugate Vaccines
1.2.5 Toxoid Vaccines
1.2.6 Recombinant Vaccines
1.2.7 DNA Vaccines
1.2.8 Others
1.3 Market by Application
1.3.1 Global Veterinary Vaccines Market Share by Application: 2018 VS 2022 VS 2030
1.3.2 Veterinary Clinic
1.3.3 Veterinary Hospital
1.3.4 Veterinary Research Institute
1.3.5 Retail Pharmacy
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Veterinary Vaccines Market Perspective (2018-2030)
2.2 Veterinary Vaccines Growth Trends by Region
2.2.1 Veterinary Vaccines Market Size by Region: 2018 VS 2022 VS 2030
2.2.2 Veterinary Vaccines Historic Market Size by Region (2018-2023)
2.2.3 Veterinary Vaccines Forecasted Market Size by Region (2023-2030)
2.3 Veterinary Vaccines Market Dynamics
2.3.1 Veterinary Vaccines Industry Trends
2.3.2 Veterinary Vaccines Market Drivers
2.3.3 Veterinary Vaccines Market Challenges
2.3.4 Veterinary Vaccines Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Veterinary Vaccines Players by Revenue
3.1.1 Global Top Veterinary Vaccines Players by Revenue (2018-2023)
3.1.2 Global Veterinary Vaccines Revenue Market Share by Players (2018-2023)
3.2 Global Veterinary Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Veterinary Vaccines Revenue
3.4 Global Veterinary Vaccines Market Concentration Ratio
3.4.1 Global Veterinary Vaccines Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Veterinary Vaccines Revenue in 2022
3.5 Veterinary Vaccines Key Players Head office and Area Served
3.6 Key Players Veterinary Vaccines Product Solution and Service
3.7 Date of Enter into Veterinary Vaccines Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Veterinary Vaccines Breakdown Data by Type
4.1 Global Veterinary Vaccines Historic Market Size by Type (2018-2023)
4.2 Global Veterinary Vaccines Forecasted Market Size by Type (2023-2030)
5 Veterinary Vaccines Breakdown Data by Application
5.1 Global Veterinary Vaccines Historic Market Size by Application (2018-2023)
5.2 Global Veterinary Vaccines Forecasted Market Size by Application (2023-2030)
6 North America
6.1 North America Veterinary Vaccines Market Size (2018-2030)
6.2 North America Veterinary Vaccines Market Size by Country (2018-2023)
6.3 North America Veterinary Vaccines Market Size by Country (2023-2030)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Veterinary Vaccines Market Size (2018-2030)
7.2 Europe Veterinary Vaccines Market Size by Country (2018-2023)
7.3 Europe Veterinary Vaccines Market Size by Country (2023-2030)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Veterinary Vaccines Market Size (2018-2030)
8.2 Asia-Pacific Veterinary Vaccines Market Size by Country (2018-2023)
8.3 Asia-Pacific Veterinary Vaccines Market Size by Country (2023-2030)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Veterinary Vaccines Market Size (2018-2030)
9.2 Latin America Veterinary Vaccines Market Size by Country (2018-2023)
9.3 Latin America Veterinary Vaccines Market Size by Country (2023-2030)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Veterinary Vaccines Market Size (2018-2030)
10.2 Middle East & Africa Veterinary Vaccines Market Size by Country (2018-2023)
10.3 Middle East & Africa Veterinary Vaccines Market Size by Country (2023-2030)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Elanco
11.1.1 Elanco Company Detail
11.1.2 Elanco Business Overview
11.1.3 Elanco Veterinary Vaccines Introduction
11.1.4 Elanco Revenue in Veterinary Vaccines Business (2018-2023)
11.1.5 Elanco Recent Development
11.2 Merck
11.2.1 Merck Company Detail
11.2.2 Merck Business Overview
11.2.3 Merck Veterinary Vaccines Introduction
11.2.4 Merck Revenue in Veterinary Vaccines Business (2018-2023)
11.2.5 Merck Recent Development
11.3 Merial
11.3.1 Merial Company Detail
11.3.2 Merial Business Overview
11.3.3 Merial Veterinary Vaccines Introduction
11.3.4 Merial Revenue in Veterinary Vaccines Business (2018-2023)
11.3.5 Merial Recent Development
11.4 Zoetis
11.4.1 Zoetis Company Detail
11.4.2 Zoetis Business Overview
11.4.3 Zoetis Veterinary Vaccines Introduction
11.4.4 Zoetis Revenue in Veterinary Vaccines Business (2018-2023)
11.4.5 Zoetis Recent Development
11.5 Advaxis
11.5.1 Advaxis Company Detail
11.5.2 Advaxis Business Overview
11.5.3 Advaxis Veterinary Vaccines Introduction
11.5.4 Advaxis Revenue in Veterinary Vaccines Business (2018-2023)
11.5.5 Advaxis Recent Development
11.6 AmpliPhi Biosciences
11.6.1 AmpliPhi Biosciences Company Detail
11.6.2 AmpliPhi Biosciences Business Overview
11.6.3 AmpliPhi Biosciences Veterinary Vaccines Introduction
11.6.4 AmpliPhi Biosciences Revenue in Veterinary Vaccines Business (2018-2023)
11.6.5 AmpliPhi Biosciences Recent Development
11.7 Aratana Therapeutics
11.7.1 Aratana Therapeutics Company Detail
11.7.2 Aratana Therapeutics Business Overview
11.7.3 Aratana Therapeutics Veterinary Vaccines Introduction
11.7.4 Aratana Therapeutics Revenue in Veterinary Vaccines Business (2018-2023)
11.7.5 Aratana Therapeutics Recent Development
11.8 ARKO Labs
11.8.1 ARKO Labs Company Detail
11.8.2 ARKO Labs Business Overview
11.8.3 ARKO Labs Veterinary Vaccines Introduction
11.8.4 ARKO Labs Revenue in Veterinary Vaccines Business (2018-2023)
11.8.5 ARKO Labs Recent Development
11.9 Bayer
11.9.1 Bayer Company Detail
11.9.2 Bayer Business Overview
11.9.3 Bayer Veterinary Vaccines Introduction
11.9.4 Bayer Revenue in Veterinary Vaccines Business (2018-2023)
11.9.5 Bayer Recent Development
11.10 CanFel Therapeutics
11.10.1 CanFel Therapeutics Company Detail
11.10.2 CanFel Therapeutics Business Overview
11.10.3 CanFel Therapeutics Veterinary Vaccines Introduction
11.10.4 CanFel Therapeutics Revenue in Veterinary Vaccines Business (2018-2023)
11.10.5 CanFel Therapeutics Recent Development
11.11 Ceva Animal Health
11.11.1 Ceva Animal Health Company Detail
11.11.2 Ceva Animal Health Business Overview
11.11.3 Ceva Animal Health Veterinary Vaccines Introduction
11.11.4 Ceva Animal Health Revenue in Veterinary Vaccines Business (2018-2023)
11.11.5 Ceva Animal Health Recent Development
11.12 Colorado Serum
11.12.1 Colorado Serum Company Detail
11.12.2 Colorado Serum Business Overview
11.12.3 Colorado Serum Veterinary Vaccines Introduction
11.12.4 Colorado Serum Revenue in Veterinary Vaccines Business (2018-2023)
11.12.5 Colorado Serum Recent Development
11.13 Epitopix
11.13.1 Epitopix Company Detail
11.13.2 Epitopix Business Overview
11.13.3 Epitopix Veterinary Vaccines Introduction
11.13.4 Epitopix Revenue in Veterinary Vaccines Business (2018-2023)
11.13.5 Epitopix Recent Development
11.14 Genus
11.14.1 Genus Company Detail
11.14.2 Genus Business Overview
11.14.3 Genus Veterinary Vaccines Introduction
11.14.4 Genus Revenue in Veterinary Vaccines Business (2018-2023)
11.14.5 Genus Recent Development
11.15 Hygieia Biological Laboratories
11.15.1 Hygieia Biological Laboratories Company Detail
11.15.2 Hygieia Biological Laboratories Business Overview
11.15.3 Hygieia Biological Laboratories Veterinary Vaccines Introduction
11.15.4 Hygieia Biological Laboratories Revenue in Veterinary Vaccines Business (2018-2023)
11.15.5 Hygieia Biological Laboratories Recent Development
11.16 ImmuCell
11.16.1 ImmuCell Company Detail
11.16.2 ImmuCell Business Overview
11.16.3 ImmuCell Veterinary Vaccines Introduction
11.16.4 ImmuCell Revenue in Veterinary Vaccines Business (2018-2023)
11.16.5 ImmuCell Recent Development
11.17 Nexvet
11.17.1 Nexvet Company Detail
11.17.2 Nexvet Business Overview
11.17.3 Nexvet Veterinary Vaccines Introduction
11.17.4 Nexvet Revenue in Veterinary Vaccines Business (2018-2023)
11.17.5 Nexvet Recent Development
11.18 Nuovo Biologics
11.18.1 Nuovo Biologics Company Detail
11.18.2 Nuovo Biologics Business Overview
11.18.3 Nuovo Biologics Veterinary Vaccines Introduction
11.18.4 Nuovo Biologics Revenue in Veterinary Vaccines Business (2018-2023)
11.18.5 Nuovo Biologics Recent Development
11.19 UBI
11.19.1 UBI Company Detail
11.19.2 UBI Business Overview
11.19.3 UBI Veterinary Vaccines Introduction
11.19.4 UBI Revenue in Veterinary Vaccines Business (2018-2023)
11.19.5 UBI Recent Development
11.20 Valneva
11.20.1 Valneva Company Detail
11.20.2 Valneva Business Overview
11.20.3 Valneva Veterinary Vaccines Introduction
11.20.4 Valneva Revenue in Veterinary Vaccines Business (2018-2023)
11.20.5 Valneva Recent Development
11.21 Vetoquinol
11.21.1 Vetoquinol Company Detail
11.21.2 Vetoquinol Business Overview
11.21.3 Vetoquinol Veterinary Vaccines Introduction
11.21.4 Vetoquinol Revenue in Veterinary Vaccines Business (2018-2023)
11.21.5 Vetoquinol Recent Development
11.22 Virbac
11.22.1 Virbac Company Detail
11.22.2 Virbac Business Overview
11.22.3 Virbac Veterinary Vaccines Introduction
11.22.4 Virbac Revenue in Veterinary Vaccines Business (2018-2023)
11.22.5 Virbac Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
